Myocardial Infarction in the Young: A Retrospective Clinical Registry Study
- Conditions
- Myocardial InfarctionCardiovascular - Coronary heart disease
- Registration Number
- ACTRN12623001097639
- Lead Sponsor
- Western Sydney Local Health District
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1000
1. Patients aged =>18 years and <=50 years old with acute myocardial infarction (MI)
2. Patients aged >50 years and with acute myocardial infarction (MI) (control group)
2. Type 1 and Type 2 MI are both included, with MI defined according to the 4th universal definition: clinical evidence of acute myocardial ischaemia and detection of a rise and/or fall of cTroponin values with at least 1 value above the 99th percentile upper reference limit and, at least one of the following:
a. Symptoms of myocardial ischaemia;
b. New ischaemic ECG changes;
c. Development of pathological Q waves;
d. Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality in a pattern consistent with an ischaemic aetiology;
e. Identification of a coronary thrombus by angiography or autopsy
3. Participants must have undergone coronary angiography
# Rise in cardiac biomarkers and/or ECG changes due to a clear non-coronary artery pathology e.g. myocarditis, acute arrhythmia, cardiomyopathy, acute pulmonary embolism (PE), stroke, recent cardiac surgery (these can all cause ischaemic changes on the ECG and/or troponin rises)
#Patients with presumed MI who die before the diagnosis has been confirmed by troponin values or coronary angiography (Type 3 MI)
#Percutaneous coronary intervention (PCI)-related MI (Type 4 MI)
#Coronary artery bypass grafting (CABG)-related MI (Type 5 MI)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method